Two Sigma Investments’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Two Sigma Investments’s Portfolio DBTX Stock Details DBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-22,308	Closed	-$68K	–	3078
2022 Q1	$68K	Sell	22,308 -25,060	-53%	-$96K	﹤0.01%	2467
2021 Q4	$220K	Buy	+47,368	New	+$326K	﹤0.01%	3862
2021 Q3	–	Sell	-34,001	Closed	-$292K	–	4871
2021 Q2	$292K	Sell	34,001 -17,318	-34%	-$153K	﹤0.01%	3535
2021 Q1	$583K	Buy	+51,319	New	+$805K	﹤0.01%	2791

Other funds holding DBTX

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

HMC

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Investments's DBTX Position: Q2 2022 in Review

Two Sigma Investments sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q2 2022, closing a stake of 22,308 shares — an estimated $68K sold.

Two Sigma Investments first reported a position in DBTX in Q1 2021 and held it in 4 quarters. The position peaked at $583K in Q1 2021. 42 funds tracked by Wall St. Rank hold DBTX as of Q2 2022.

Two Sigma Investments reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Two Sigma Investments sold 22,308 Decibel Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $68K.
Two Sigma Investments first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
Two Sigma Investments's Decibel Therapeutics, Inc. Common Stock position peaked at $583K in Q1 2021.
42 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.